These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1390319)

  • 1. Cholesterol lowering and the reduction of CHD incidence and total mortality: results from a meta-analysis of randomized trials.
    Holme I
    Cardiovasc Drugs Ther; 1992 Apr; 6(2):101-2. PubMed ID: 1390319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol reduction in single and multifactor randomized trials: relationship to CHD incidence and total mortality as found by meta analysis of twenty-two trials.
    Holme I
    Blood Press Suppl; 1992; 4():29-34. PubMed ID: 1345332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.
    Holme I
    Circulation; 1990 Dec; 82(6):1916-24. PubMed ID: 2242517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol lowering and mortality: the importance of considering initial level of risk.
    Smith GD; Song F; Sheldon TA
    BMJ; 1993 May; 306(6889):1367-73. PubMed ID: 8518602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol reduction yields clinical benefits: meta-analysis including recent trials.
    Gould AL; Davies GM; Alemao E; Yin DD; Cook JR
    Clin Ther; 2007 May; 29(5):778-794. PubMed ID: 17697899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol reduction yields clinical benefit: impact of statin trials.
    Gould AL; Rossouw JE; Santanello NC; Heyse JF; Furberg CD
    Circulation; 1998 Mar; 97(10):946-52. PubMed ID: 9529261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [All mortality by cause of death. The challenge of coronary prevention].
    Fernández-Cruz A
    Rev Esp Cardiol; 1998; 51 Suppl 6():23-9. PubMed ID: 10050141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol reduction yields clinical benefit. A new look at old data.
    Gould AL; Rossouw JE; Santanello NC; Heyse JF; Furberg CD
    Circulation; 1995 Apr; 91(8):2274-82. PubMed ID: 7697857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-benefit analysis of a plant sterol containing low-fat margarine for cholesterol reduction.
    Gerber A; Evers T; Haverkamp H; Lauterbach KW
    Eur J Health Econ; 2006 Dec; 7(4):247-54. PubMed ID: 16821072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
    JAMA; 1984 Jan; 251(3):351-64. PubMed ID: 6361299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 1. A meta-analysis of cholesterol-lowering trials.
    Silberberg JS; Henry DA
    Med J Aust; 1991 Nov; 155(10):665-6, 669-70. PubMed ID: 1834922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and regression of coronary atherosclerosis. Is it safe and efficacious therapy?
    Montague T; Tsuyuki R; Burton J; Williams R; Dzavik V; Teo K
    Chest; 1994 Mar; 105(3):718-26. PubMed ID: 8131532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol, primary and secondary prevention, and all-cause mortality.
    Criqui MH
    Ann Intern Med; 1991 Dec; 115(12):973-6. PubMed ID: 1835327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between total mortality and cholesterol reduction as found by meta-regression analysis of randomized cholesterol-lowering trials.
    Holme I
    Control Clin Trials; 1996 Feb; 17(1):13-22. PubMed ID: 8721798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trials of cholesterol lowering for the secondary prevention of coronary heart disease].
    Koizumi J
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():252-6. PubMed ID: 17821900
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome.
    Ravnskov U
    BMJ; 1992 Jul; 305(6844):15-9. PubMed ID: 1638188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol screening in asymptomatic adults, revisited. Part 2.
    Garber AM; Browner WS; Hulley SB
    Ann Intern Med; 1996 Mar; 124(5):518-31. PubMed ID: 8602715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.
    LaRosa JC; He J; Vupputuri S
    JAMA; 1999 Dec 22-29; 282(24):2340-6. PubMed ID: 10612322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.